These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 203643)

  • 1. Influence of substance P on hypothalamo-pituitary-adrenocorticol activity in the rat.
    Jones MT; Gillham B; Holmes MC; Hodges JR; Buckingham JC
    J Endocrinol; 1978 Jan; 76(1):183-4. PubMed ID: 203643
    [No Abstract]   [Full Text] [Related]  

  • 2. Rat melanin concentrating hormone does not modify the release of CRH-41 from rat hypothalamus or ACTH from the anterior pituitary in vitro.
    Navarra P; Tsagarakis S; Coy DH; Rees LH; Besser GM; Grossman AB
    J Endocrinol; 1990 Oct; 127(1):R1-4. PubMed ID: 1966496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of triptolide on hypothalamic-pituitary-adrenal axis of rats].
    Zhu JH; Hu YL; Zhang W; Guan W; Huang GZ
    Fa Yi Xue Za Zhi; 2010 Aug; 26(4):260-5. PubMed ID: 20967951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
    Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol induced alteration of immune function may involve hormones of the hypothalamic-pituitary-adrenal axis.
    Redei E; Clark WR; McGivern RF
    Prog Clin Biol Res; 1990; 325():313-20. PubMed ID: 2153986
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of lipopolysaccharide on hypothalamic-pituitary-adrenal axis in vitro.
    Brunetti L; Preziosi P; Ragazzoni E; Vacca M
    Life Sci; 1994; 54(10):PL165-71. PubMed ID: 8107506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.
    Buckingham JC
    J Physiol; 1979 Jan; 286():331-42. PubMed ID: 220413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P afferents regulate ACTH-corticosterone release.
    Donnerer J; Amann R; Skofitsch G; Lembeck F
    Ann N Y Acad Sci; 1991; 632():296-303. PubMed ID: 1719873
    [No Abstract]   [Full Text] [Related]  

  • 10. Functioning of the hypothalamo-pituitary-adrenal system during postnatal development in rats.
    Bartová A
    Gen Comp Endocrinol; 1968 Apr; 10(2):235-9. PubMed ID: 4297497
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone secretagogues as corticotrophin-releasing factors.
    Ghigo E; Arvat E; Camanni F
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():145-8. PubMed ID: 10990151
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
    J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G; Ixart G; Tapia-Arancibia L; Givalois L
    Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats.
    Dewey WL; Peng TC; Harris LS
    Eur J Pharmacol; 1970; 12(3):382-4. PubMed ID: 4322071
    [No Abstract]   [Full Text] [Related]  

  • 15. Some aspects of corticosteroid feedback actions.
    Smelik PG
    Ann N Y Acad Sci; 1977 Oct; 297():580-90. PubMed ID: 211919
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in hypothalamic-pituitary responsiveness during lactation.
    Lightman SL
    Ann N Y Acad Sci; 1992 Jun; 652():340-6. PubMed ID: 1320830
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ; Edwards E; Nemeroff CB
    Eur J Pharmacol; 1990 Nov; 190(1-2):113-22. PubMed ID: 1963847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a specific dopaminergic blocking agent, pimozide, on hypothalamic corticotropin-releasing-factor activity in rats: clinical correlates.
    Upton GV; Corbin A
    Experientia; 1975 Feb; 31(2):249-50. PubMed ID: 1078659
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF).
    Rivier C; Bruhn T; Vale W
    J Pharmacol Exp Ther; 1984 Apr; 229(1):127-31. PubMed ID: 6323684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.